Skip to main content
. Author manuscript; available in PMC: 2010 Jul 9.
Published in final edited form as: Neuropsychopharmacology. 2009 Dec 30;35(5):1165–1173. doi: 10.1038/npp.2009.221

Figure 3.

Figure 3

Relationships between percentage changes in prefrontal NAA levels over the 4-week treatment period and the total number of negative urine results in CDP-choline-treated MA-dependent patients. Scatter plots were depicted based on 12 CDP-choline-treated patients whose second follow-up MRS scan at 4 weeks was available. CDP-choline, cytidine-5′ diphosphate choline; MA, methamphetamine; NAA, N-acetyl-aspartate/N-acetyl-aspartyl glutamate.